Brain Stem Gliomas Completed Phase 1 Trials for Aldesleukin (DB00041)

Also known as: Brain Stem Glioma / Brainstem Glioma / Glioma of brainstem

IndicationStatusPhase
DBCOND0087392 (Brain Stem Gliomas)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01082926Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination With Interleukin-2Treatment